RNA-Binding Protein FXR1 Regulates p21 and TERC RNA to Bypass p53-Mediated Cellular Senescence in OSCC
Mrinmoyee Majumder1, Reniqua House1, Nallasivam Palanisamy2
1Department of Oral Health Sciences and Center for Oral Health Research, College of Dental Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.
Abstract:
RNA-binding proteins (RBP) regulate numerous aspects of co- and post-transcriptional gene expression in cancer cells. Here, we demonstrate that RBP, fragile X-related protein 1 (FXR1), plays an essential role in cellular senescence by utilizing mRNA turnover pathway. We report that overexpressed FXR1 in head and neck squamous cell carcinoma targets (G-quadruplex (G4) RNA structure within) both mRNA encoding p21 (Cyclin-Dependent Kinase Inhibitor 1A (CDKN1A, Cip1) and the non-coding RNA Telomerase RNA Component (TERC), and regulates their turnover to avoid senescence. Silencing of FXR1 in cancer cells triggers the activation of Cyclin-Dependent Kinase Inhibitors, p53, increases DNA damage, and ultimately, cellular senescence. Overexpressed FXR1 binds and destabilizes p21 mRNA, subsequently reduces p21 protein expression in oral cancer cells. In addition, FXR1 also binds and stabilizes TERC RNA and suppresses the cellular senescence possibly through telomerase activity. Finally, we report that FXR1-regulated senescence is irreversible and FXR1-depleted cells fail to form colonies to re-enter cellular proliferation. Collectively, FXR1 displays a novel mechanism of controlling the expression of p21 through p53-dependent manner to bypass cellular senescence in oral cancer cells.
Insights
Fragile X-related protein 1 (FXR1) prevents cellular senescence in oral cancer by regulating p21 mRNA and Telomerase RNA Component (TERC). Silencing FXR1 triggers senescence, inhibiting cancer cell proliferation.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- RNA-binding proteins (RBPs) control gene expression post-transcriptionally.
- Cellular senescence is a critical tumor suppressor mechanism.
- Dysregulation of RBPs contributes to cancer development.
Purpose of the Study:
- To investigate the role of fragile X-related protein 1 (FXR1) in regulating cellular senescence in cancer.
- To elucidate the molecular mechanisms by which FXR1 influences senescence pathways.
- To determine the therapeutic potential of targeting FXR1 in oral cancer.
Main Methods:
- Quantitative PCR and Western blotting to assess gene and protein expression.
- RNA immunoprecipitation (RIP) assays to identify FXR1 RNA targets.
- Cell viability and colony formation assays to evaluate proliferation and senescence.
Main Results:
- Overexpressed FXR1 targets p21 mRNA and Telomerase RNA Component (TERC) RNA, regulating their turnover.
- FXR1 silencing in oral cancer cells induces p53 activation, DNA damage, and cellular senescence.
- FXR1 binds and destabilizes p21 mRNA, reducing p21 protein, and stabilizes TERC RNA, potentially suppressing senescence via telomerase.
Conclusions:
- FXR1 plays a crucial role in bypassing cellular senescence in oral cancer through p53-dependent regulation of p21.
- FXR1-mediated suppression of senescence is irreversible, leading to a loss of proliferative capacity in cancer cells.
- FXR1 represents a novel therapeutic target for reactivating senescence and inhibiting oral cancer progression.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Replicative Cell Senescence
Replicative Cell Senescence
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle


